By Abigail Townsend
Date: Wednesday 30 Apr 2025
(Sharecast News) - GSK reiterated shrugged off the potential impact of tariffs on Wednesday and reiterated its full-year outlook, following a strong start to the year.
The blue chip drugs giant said total sales rose 2% in the first quarter, or by 4% on a constant currency basis, to £7.52bn. or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news